oxyphenbutazone and sulindac

oxyphenbutazone has been researched along with sulindac in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Kumar, M; Sinha, VR; Thareja, S1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Burdeĭnyĭ, AP1
Koren, L; Nahir, AM; Scharf, Y1
Blake, JW; Tobin, T; Weckman, T; Woods, WE1
Isenman, DE; Minta, JO; Smythe, HA; Urowitz, MB1
Cotlier, E; Sharma, YR1

Reviews

1 review(s) available for oxyphenbutazone and sulindac

ArticleYear
[Drug therapy of ankylosing spondyloarthritis (Bechterew's disease)].
    Terapevticheskii arkhiv, 1978, Volume: 50, Issue:12

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Apazone; Butadienes; Cyclophosphamide; Diclofenac; Drug Combinations; Drug Evaluation; Glycolates; Gold; Humans; Ibuprofen; Indomethacin; Ketoprofen; Levamisole; Naproxen; Oxyphenbutazone; Phenylbutazone; Salicylates; Spondylitis, Ankylosing; Sulindac

1978

Other Studies

8 other study(ies) available for oxyphenbutazone and sulindac

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
    European journal of medicinal chemistry, 2012, Volume: 53

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
[Sulindac in ankylosing spondylitis].
    Harefuah, 1978, May-15, Volume: 94, Issue:10

    Topics: Humans; Indenes; Oxyphenbutazone; Spondylitis, Ankylosing; Sulindac

1978
Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.
    Journal of pharmacological methods, 1986, Volume: 16, Issue:4

    Topics: Animals; Chromatography, Thin Layer; Diclofenac; Female; Fenoprofen; Horses; Hydrogen-Ion Concentration; Ibuprofen; Oxyphenbutazone; Pharmaceutical Preparations; Phenylbutazone; Piroxicam; Sulindac

1986
Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.
    Clinical and experimental immunology, 1983, Volume: 53, Issue:3

    Topics: Anti-Inflammatory Agents; Aspirin; Centrifugation, Density Gradient; Chromatography, Gel; Complement C3b Inactivator Proteins; Complement C5; Complement Inactivator Proteins; Complement Pathway, Classical; Dose-Response Relationship, Drug; Hemolysis; Humans; In Vitro Techniques; Indomethacin; Macromolecular Substances; Oxyphenbutazone; Phenylbutazone; Sulindac

1983
Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
    Experimental eye research, 1982, Volume: 35, Issue:1

    Topics: Aged; Aldehyde Reductase; Animals; Anti-Inflammatory Agents; Cataract; Cattle; Humans; Indomethacin; Lens, Crystalline; Middle Aged; Organ Culture Techniques; Oxyphenbutazone; Protein Binding; Rats; Sodium Salicylate; Sugar Alcohol Dehydrogenases; Sulindac

1982